» Articles » PMID: 96137

Quantitative Influence of Antibody and Complement Coating of Red Cells on Monocyte-mediated Cell Lysis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1978 May 1
PMID 96137
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Monocyte-mediated lysis in vitro of human red cells coated with measured amounts of immunoglobulin G (IgG) or complement were studied. 1,000-1,500 molecules of IgG anti-D are necessary to effect measurable lysis, and lysis increases linearly with increasing levels of antibody sensitization. 100 microgram/ml of IgG1 abolished lysis even at maximal levels of anti-D sensitization (15,000 molecules/cell). Two isoimmune IgG anti-A or anti-B antisera were 5 to 10-fold less efficient in promoting phagocytosis or lysis per molecule of IgG bound; however, because of the greater antigen density of A or B, more than 100,000 molecules IgG/cell could be bound, producing equivalent lysis to anti-D-coated cells. Although inhibition by IgG1 was similar at equivalent levels of sensitization with anti-A, anti-B, or anti-D at high levels of coating with anti-A or anti-B (not attainable with anti-D), lysis was not inhibited by IgG1. Cells coated with human complement components alone were not lysed by monocytes; however, complement coating augmented IgG-mediated lysis and reduced the quantity of anti-D necessary to produce lysis to less than 1,000 molecules/cell. After thorough degradation of C3b by serum to C3d, complement augmentation persisted.

Citing Articles

Predictors of Drug Retention and Survival Rate of bDMARDs in Rheumatoid Arthritis: A Four-Year Real-Life Tunisian Experience.

Boussaid S, Tbini H, Rekik S, Khaled S, Rahmouni S, Zouaoui K Mediterr J Rheumatol. 2024; 35(3):448-458.

PMID: 39463880 PMC: 11500116. DOI: 10.31138/mjr.090723.pof.


F-fluorodeoxyglucose positron emission tomography-computed tomography for assessing organ distribution of stressed red blood cells in mice.

Yin W, Yuan J, Zhang Z, Mei C, Xu W, Tang Y Sci Rep. 2021; 11(1):2505.

PMID: 33510312 PMC: 7844045. DOI: 10.1038/s41598-021-82100-y.


Immunoglobulin M: An Ancient Antiviral Weapon - Rediscovered.

Gong S, Ruprecht R Front Immunol. 2020; 11:1943.

PMID: 32849652 PMC: 7432194. DOI: 10.3389/fimmu.2020.01943.


Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions.

Pandey P, Anani W, Pugh T, Gottschall J, Denomme G J Transl Med. 2020; 18(1):216.

PMID: 32466782 PMC: 7257204. DOI: 10.1186/s12967-020-02378-w.


Common Variable Immunodeficiency Non-Infectious Disease Endotypes Redefined Using Unbiased Network Clustering in Large Electronic Datasets.

Farmer J, Ong M, Barmettler S, Yonker L, Fuleihan R, Sullivan K Front Immunol. 2018; 8:1740.

PMID: 29375540 PMC: 5767273. DOI: 10.3389/fimmu.2017.01740.


References
1.
Ross G, Polley M . Specificity of human lymphocyte complement receptors. J Exp Med. 1975; 141(5):1163-80. PMC: 2189795. DOI: 10.1084/jem.141.5.1163. View

2.
Rosse W . Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment. J Clin Invest. 1971; 50(4):734-43. PMC: 291987. DOI: 10.1172/JCI106544. View

3.
Poplack D, Bonnard G, Holiman B, Blaese R . Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood. 1976; 48(6):809-16. View

4.
GILLILAND B . Coombs--negative immune hemolytic anemia. Semin Hematol. 1976; 13(4):267-75. View

5.
Logue G, ROSSE W . Immunologic mechanisms in autoimmune hemolytic disease. Semin Hematol. 1976; 13(4):277-89. View